| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2010.29.2870 |
| P953 | full work available at URL | http://intl.jco.org/cgi/content/abstract/28/30/4551 |
| https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.29.2870 | ||
| P698 | PubMed publication ID | 20837954 |
| P2093 | author name string | Jean-Charles Soria | |
| Dominique Bellet | |||
| Lydia Aldaz-Carroll | |||
| Marc Pocard | |||
| P2860 | cites work | Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies | Q33985780 |
| Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice | Q37058731 | ||
| Phase 0 clinical trials in oncology: a paradigm shift for early drug development? | Q37211870 | ||
| Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors | Q43182188 | ||
| The ethics of phase 0 oncology trials | Q44552692 | ||
| Phase 0 clinical trials: an answer to drug development stagnation? | Q46052036 | ||
| A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer | Q46689589 | ||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4551-4553 | |
| P577 | publication date | 2010-09-13 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Phase 0 clinical trials in oncology: an exploratory methodology for constructing a study with patients undergoing surgery for metastatic disease | |
| Phase 0 Clinical Trials in Oncology: An Exploratory Methodology for Constructing a Study With Patients Undergoing Surgery for Metastatic Disease | |||
| P478 | volume | 28 |
Search more.